Page - (000196) - in Biomedical Chemistry: Current Trends and Developments

Abi-Dargham, A., O. Mawlawi, et al. (2002). Prefrontal dopamine D1 receptors and working memory in schizophrenia. The Journal of Neuroscience, 22(9), 3708-3719. Aceves, J., B. Floran, et al. (1995). D-1 receptor mediated modulation of the release of gamma- aminobutyric acid by endogenous dopamine in the basal ganglia of the rat. Progress in Neuropsychopharmacology & Biological Psychiatry, 19(5), 727-739. Agay, N., E. Yechiam, et al. (2010). Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology, 210(4): 511- 519. Albert, P. R., F. Vahid-Ansari, et al. (2014). Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression. Frontiers in Behavioral Neuroscience, 8, 199. Albrecht, J., U. Sonnewald, et al. (2007). Glutamine in the central nervous system: function and dysfunction. Frontiers in Bioscience, 12, 332-343. Allen, N. J., D. J. Rossi, et al. (2004). Sequential release of GABA by exocytosis and reversed uptake leads to neuronal swelling in simulated ischemia of hippocampal slices. The Journal of Neuroscience, 24(15), 3837-3849. Ampe, B., A. Massie, et al. (2007). “NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats.” Journal of neurochemistry 103(3): 1063-1074. Araque, A., G. Carmignoto, et al. (2014). Gliotransmitters travel in time and space. Neuron 81(4): 728-739. Astrup, J., B. K. Siesjo, et al. (1981). Thresholds in cerebral ischemia - the ischemic penumbra. Stroke, 12(6), 723-725. Baker, D. A., K. McFarland, et al. (2003). Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nature Neuroscience, 6(7), 743-749. Balsters, J. H., R. G. O’Connell, et al. (2011). Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkers. PLoS One, 6(9), e24126. Bassareo, V., M. A. De Luca, et al. (2002). Differential expression of motivational stimulus properties by dopamine in nucleus accumbens shell versus core and prefrontal cortex. The Journal of Neuroscience, 22(11), 4709-4719. Bauer, D., D. Gupta, et al. (2008). Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophrenia Research, 104(1-3), 108-120. Becker, H. C. and P. J. Mulholland (2014). Neurochemical mechanisms of alcohol withdrawal. Handbook of Clinical Neurology, 125, 133-156. Ben-Ari, Y. (2002). Excitatory actions of gaba during development: the nature of the nurture. Nature reviews. Neuroscience, 3(9), 728-739. Betarbet, R., T. B. Sherer, et al. (2002). Mechanistic approaches to Parkinson’s disease pathogenesis. Brain Pathology, 12(4) 499-510. Bettler, B. and J. Y. Tiao (2006). Molecular diversity, trafficking and subcellular localization of GABAB receptors. Pharmacology & Therapeutics, 110(3), 533-543. Blandini, F. (2010). An update on the potential role of excitotoxicity in the pathogenesis of Parkinson’s disease. Functional Neurology, 25(2), 65-71.